CG Oncology (CGON) announced the appointment of Christina Rossi to its Board of Directors. Additionally, Simone Song, Senior Partner, ORI Capital, has resigned from the Board effective November 22, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGON:
- CG Oncology initiated with a Buy at Truist
- CG Oncology price target raised to $61 from $53 at RBC Capital
- CG Oncology, Inc.: Promising Future with Creto’s Accelerated Approval Path and Market Differentiation
- Strategic Advancements and Risk Mitigation Drive Buy Rating for CG Oncology, Inc.
- CG Oncology Advances Bladder Cancer Therapy Development